化学发光酶联免疫分析检测血清中麻疹病毒抗体

化学发光酶联免疫分析检测血清中麻疹病毒抗体章竹君，邹克渭，程明洁（陕西师范大学分析科学研究所，西安，７１００６２）（陕西省卫生防疫站）关键词麻疹病毒抗体，化学发光，酶联免疫分析，辣根过氧化物酶目前在计划免疫工作中通常采用间接酶联免疫吸附分析法（ＥＬＩ...     

红细胞标记抗体的化学发光免疫分析

用红细胞代替辣根过氧化物酶作为双抗体夹心免疫分析中第二抗体的标记物, 建立了一种红细胞标记抗体的免疫化学发光测定乙型肝炎病毒表面抗原的新方法. 在免疫反应完成后, 结合了抗原-抗体免疫复合物的致敏红细胞在低渗溶液中溶血, 释放出血红蛋白. 基于血红蛋白对鲁米诺-H2O2体系化学发光具有催化作用的原理, 采用化学发光法测定血红蛋白含量. 测得的血红蛋白发光强度与待测抗原浓度呈线性关系. 采用这种方法可检测出0.5 ng/mL的乙型肝炎病毒表面抗原. 将该方法与酶联免疫吸附分析(ELISA)结合起来对乙型肝炎患者血清乙肝病毒表面抗原(HBsAg)进行检测, 两者符合率均为97%, 表明本法具有良好的灵敏度和特异性, 可用于临床标本测试.     

培氟沙星抗体的制备及对鸡蛋样品中培氟沙星的酶联免疫法检测

采用活泼酯法合成培氟沙星人工抗原,通过免疫新西兰大白兔获得抗体,建立了间接竞争酶联免疫法(ELISA)检测鸡蛋中培氟沙星。人工抗原经紫外光谱和红外光谱鉴定,免疫所获得抗体测得效价高达1∶51 200,继而建立了培氟沙星间接竞争ELISA,标准曲线线性相关系数为0.9920,Ic50达1.5μg/L,抗体对恩诺沙星的交叉反应率为13.89%;鸡蛋样品中分别添加不同浓度的培氟沙星和恩诺沙星,经乙腈-水溶液(体积比4∶1)提取,离心稀释后经ELISA检测,结果表明培氟沙星和恩诺沙星加标回收率为分别为90%～94.2%、84%～90.3%,相对标准偏差分别为5.2%～10.0%、6.5%～10.3%。该方法具有灵敏度高、样品前处理简单、批量检测的优点,适用于复杂食品基质中培氟沙星的定量检测。     

合并血浆中病毒标记检测临界值的确定分析

确保合并血浆检测结果的判定准确可靠,能够有效保证合并血浆的病毒安全性,对合并血浆乙型肝炎病毒表面抗原、丙型肝炎病毒抗体、人类免疫缺陷病毒抗体检测时不同厂家检测试剂的临界值进行确定。(1)使用双抗体夹心酶联免疫法对合并血浆HBsAg和HIV-1/HIV-2抗体的检测临界值进行确定。(2)使用酶联免疫法检测合并血浆HCV抗体的临界值进行确定。经检测和计算,两个厂家检测试剂的检测临界值系数分别为乙型肝炎病毒表面抗原23.398%和26.845%、丙型肝炎病毒抗体9.012%和16.481%、人类免疫缺陷病毒抗体20.025%和23.424%。     

化学发光酶联免疫分析测定血清中抗DNA抗体

建立起适于临床应用的抗ＤＮＡ抗体化学发光酶联免疫分析法。该法精密度良好，相对标准偏差为２．４％。比ＥＬＩＳＡ法更加简便、经济、省时，同时提高了灵敏度（８倍）和血清的阳性检出率。探讨了检测系统中对碘苯酚增强鲁米诺－过氧化氢－辣根过氧化物酶化学发光反应机理。     

细交链格孢菌酮酸间接竞争酶联免疫检测方法及配套试剂盒的研制

建立了间接竞争酶联免疫吸附法检测食品中细交链格孢酮酸(Tenuazonic Acid,TA)残留,并研制快速检测试剂盒。采用肟化法对TA进行衍生化,活泼酯法偶联半抗原和载体蛋白得到人工抗原TAO-BSA和TAO-KLH,以TAO-KLH作为免疫原免疫雌性Balb/c小鼠制备特异性抗体。对包被浓度、包被时间、封闭液类型、抗体工作浓度、二抗稀释度、底物显色时间等参数进行研究,建立了TA残留间接竞争酶联免疫检测方法并进行了配套试剂盒的研制。该试剂盒半抑制浓度Ic_(50)为1.48ng/mL,检测线性范围为0.06~35.95ng/mL(R~2=0.9941);检测限为0.02ng/mL;加标样品平均回收率大于88.50%;试剂盒的批间和批内平均变异系数分别为2.84%和9.49%,与食品中常见真菌毒素交叉反应率均小于1%。     

对克伦特罗具有高特异性的酶联免疫吸附分析法研究

合成了克伦特罗(CL)半抗原2-(1-(4-氨基-3,5-二氯苯基)-2-(叔丁胺基)乙氧基)乙酸,采用活性酯法将半抗原与牛血清白蛋白偶联合成免疫原,经免疫、分离、纯化获得抗CL多克隆抗体,建立了对CL具高特异性的直接竞争酶联免疫吸附分析(dc-ELISA)法。本方法对CL检测的线性浓度范围为1.0×10!4～1.0 mg/L,定量检测下限为0.13μg/L。在尿样中添加CL标准至含量分别为10.0和1.0μg/L,dc-ELISA法检测的回收率分别为90.0%～115.9%和80.5%～112.4%;相对标准偏差(RSD)分别为7.1%和12.6%(n=10)。特异性实验结果表明:抗体与CL结构类似物沙丁胺醇(SAL)的交叉反应率<0.3%,因此本研究所制备的抗体可有效避免现有克伦特罗ELISA试剂盒、胶体金检测试纸假阳性率高的问题。     

麻疹病毒抗体的酶免疫电化学分析法研究

建立了测定麻疹病毒抗体的酶免疫电化学分析法。其原理是在异相酶联免疫之后用极谱法检测酶促产物。本法采用小型三电极系统“ＤＭＥ－Ｐｔ－Ａｇ／ＡｇＣｌ”直接与商品酶联板配套使用，简化了操作步骤。对测定麻疹抗体的合适条件以及灵敏度，特异性等作了考察。结果表明，本法特异性强，灵敏度高，检测范围宽，不受样品颜色、浊度、杂散光及酶联板自身光吸收不均一的影响；应用于测定三批共１１８份血清样品，阳性率分别为１５％（６／４０），６２．５％（２５／４０）和３１．５８％（１２／３８），用４６份样品对本法和ＥＬＩＳＡ作相关性检验，其相关性良好（γ＝０．７７．ｔ＿ｒ＝１０．８４，Ｐ＜０．００１，相关显著）。     

荧光免疫法测定生物样品中的氯胺酮

制备了氯胺酮的多克隆抗体,以间接酶联免疫吸附法为基础,异硫氰酸荧光素为荧光探针,建立了检测氯胺酮的荧光免疫法。在优化的反应条件下,方法的线性范围为1～1000μg/L,检出限为0.48μg/L。不同浓度的氯胺酮在人体血清和尿液样品中的加标回收率在99%～107%。方法适用于生物样品中氯胺酮的检测。     

酶联免疫法检测海洋贝类中的荧蒽

分别以BSA和OVA为载体蛋白,利用活化酯法和混合酸酐法合成了荧蒽的免疫原和包被原,对新西兰大白兔进行免疫,制备出效价较高、特异性较好的荧蒽多克隆抗体。建立出一种检测贝类中荧蒽的间接竞争酶联免疫吸附方法(ic-ELISA),优化了包被原、一抗、二抗工作浓度,包被时间、抗原抗体反应时间及封闭液等实验检测条件。该方法特异性强,稳定性和灵敏度高,线性回归方程为y=19. 97x+15. 495 (R2=0. 99),线性范围为1～500 ng/mL,IC50为53 ng/mL,检出限为0. 94 ng/mL,回收率为81. 3%～102. 5%,RSD为2. 5%～8. 9%。将该法应用于实际贝类样品的检测,检测结果和HPLC相比,具有较好的相关性,该方法可用于实际样品中荧蒽的快速分析检测。     

Construction of Recombinant Fowlpox Virus （rFpv） Expressing HIV-1 Gag-pol Protein

IntroductionWHO estimated that currently there are more than40 million individuals living with HIV and there are16000 new individuals infected daily worldwide. HIVstimulates strong immune CD8 cytotoxic T lympho-cytes(CTL) response in the infected people…     

Synergistic Effect by Combining a gp120-Binding Protein and a gp41-Binding Antibody to Inactivate HIV-1 Virions and Inhibit HIV-1 Infection

Acquired immune deficiency syndrome (AIDS) has prevailed over the last 30 years. Although highly active antiretroviral therapy (HAART) has decreased mortality and efficiently controlled the progression of disease, no vaccine or curative drugs have been approved until now. A viral inactivator is expected to inactivate cell-free virions in the absence of target cells. Previously, we identified a gp120-binding protein, mD1.22, which can inactivate laboratory-adapted HIV-1. In this study, we have found that the gp41 N-terminal heptad repeat (NHR)-binding antibody D5 single-chain variable fragment (scFv) alone cannot inactivate HIV-1 at the high concentration tested. However, D5 scFv in the combination could enhance inactivation activity of mD1.22 against divergent HIV-1 strains, including HIV-1 laboratory-adapted strains, primary HIV-1 isolates, T20- and AZT-resistant strains, and LRA-reactivated virions. Combining mD1.22 and D5 scFv exhibited synergistic effect on inhibition of infection by divergent HIV-1 strains. These results suggest good potential to develop the strategy of combining a gp120-binding protein and a gp41-binding antibody for the treatment of HIV-1 infection.     

Preparation and Characterization of Olaquindox Polyclonal Antibody

本研究先将喹乙醇琥珀酸单酯化,使其转变为带有羧基的衍生物。合成产物经重结晶纯化,得率为52.47%。合成产物进行结构鉴定,合成了具有喹乙醇分子结构特征的喹乙醇半抗原。采用活化酯法将半抗原与牛血清白蛋白（BSA）进行偶联,采用混合酸酐法将半抗原与卵清蛋白（OVA）进行偶联,分别制备免疫原和包被抗原。紫外扫描与红外图谱分析结果表明,半抗原与载体蛋白偶联成功,与BSA、OVA的结合比分别为3.8:1和5.0:1。以OLA-BSA作为免疫原免疫4只新西兰大白兔,获得了较高效价的抗血清,以OLA-OVA作为包被抗原,间接ELISA法测定各兔的效价,分别为1:6400;1:1600;1:12800;1:6400。间接ELISA法喹乙醇的抑制中浓度IC50为743.3 ng/mL,最低检测限IC20为5.71 ng/mL。从电泳图谱分析可以看出,经纯化得到了纯度较高的喹乙醇多克隆抗体,为喹乙醇免疫分析方法的进一步研制和开发奠定基础。     

Nonrandom features of the human immunoglobulin variable region gene repertoire expressed in response to HIV-1

Characterization of the immune response toward HIV is important for understanding the basic mechanisms of the disease and may give essential information for development of an anti-HIV vaccine. Paradoxically, although HIV infection is associated with a strong antibody response to structural and nonstructural HIV proteins, this immune response does not seem to halt disease progression. Both quantitative and qualitative B-cell abnormalities are associated with disease progression. The immunological abnormalities in HIV-1 infection include abnormal cytokine production and expansion of HIV-1-specific B-cell precursors that may reach 40%. There is also evidence that gpl20 exerts a B-cell superantigen-like activity on human B-cells through binding to gene products of the third heavy-chain variable region family (VH3). This property of gpl20 may induce abnormal mechanisms of selection of the antibody repertoire. It may also account for the apparent paucity of anti-gpl20 antibodies expressing VH3 genes and for the polyclonal activation seen in the early stages of HIV infection. This expansion would reflect specific stimulation of VH3 B-cells, but not all B-cells. It would then be followed by a significant deletion of this B-cell subset. Finally, autoimmune phenomena have been described in HIV infection, and several hypotheses have been put forward to account for such associations. On the basis of the superantigen concept discussed above, one may suggest that gpl20 may trigger B-cell subsets bearing receptors with specificities for self-components. This would explain the multiplicity of autoantibody specificities seen in this disease.     

Design of Sensitive Biocompatible Quantum‐Dots Embedded in Mesoporous Silica Microspheres for the Quantitative Immunoassay of Human Immunodeficiency Virus‐1 Antibodies

A novel sandwich‐type electrochemiluminescence (ECL) immunosensor was developed to enable the sensitive detection of HIV‐1 antibodies. This system incorporated mesoporous silica (mSiO₂) complexed with quantum dots (QDs) and nano‐gold particles, which were assembled to enhance signal detection. Magnetic beads were used by immobilizing the secondary anti‐IgG antibody. This was first employed to capture HIV‐1 antibody (Ab) to form a Fe₃O₄/anti‐IgG/Ab complex. A high loading and signal‐enhanced nanocomposite (hereafter referred to as Au‐mSiO₂‐CdTe) was used as a HIV‐1 antigen label. The Au‐mSiO₂‐CdTe nanocomposite was conjugated with the Fe₃O₄/anti‐IgG/Ab complex to form an immunocomplex (hereafter referred to as Fe₃O₄/anti‐IgG/Ab/HIV‐1/CdTe‐mSiO₂‐Au). This complex could be further separated by an external magnetic field to produce ECL signals. Due to the large specific surface area and pore volume of mSiO₂, the loading of the CdTe QDs was markedly increased. Thus, the loaded QDs released a powerful chemiluminescent signal with a concordantly increased sensitivity of the immunosensor. The immunosensor was highly sensitive, and displayed a linear range of responses for HIV‐1 antibody across a dilution range of 1 : 1500 through 1 : 50 with the detection limit of 1 : 4500. The immunoassay can be a promising candidate in early diagnosis of HIV infection.     

细交链孢菌酮酸酶联免疫吸附分析方法研究

采用水合肼和乙醛酸依次对细交链孢菌酮酸(Tenuazonic acid,TeA)进行衍生化,设计合成了含有氮杂共轭双键偶联手臂,可增强免疫效果的半抗原TeAHGA.通过偶联载体蛋白BSA后的免疫原TeAHGABSA免疫新西兰大白兔,成功制备了特异性识别TeA水合肼衍生物TeAH的多克隆抗体;优化确立了ELISA最佳反应条件(TeAH-OVA为异源包被原、包被浓度0.156 μg/L、药物稀释及反应缓冲液为PBS、一抗反应时间40 min、二抗反应时间20 min),建立了TeA间接竞争ELISA(icELISA)检测方法,其抑制中浓度(IC50)为1.61 μg/L,检出限(LOD)为0.08 μg/L,定量线性检测范围为0.19～12.89 μg/L (IC20～IC80).番茄、面粉样品平均添加回收率分别为67.2％～89.8％和74.8％～93.7％.     

Syntheses of new difluoromethylene benzoxazole and 1,2,4-oxadiazole derivatives, as potent non-nucleoside HIV-1 reverse transcriptase inhibitors

In an effort to prepare new fluorine-containing compounds, which are active against HIV, several chemical modifications of a series of benzoxazole and 1,2,4-oxadiazole-CF₂CHOHAr derivatives were carried out. The products (9-30) which all have one or two CF₂ groups were tested for activity against HIV-1; they were devoid of significant activity, one of them being cytotoxic.